Delivery Order SPE2DB20D1004-SPE2DB23FG3R0
Award Date 8/10/23
Potential Completion Date 8/11/23
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the medication Repatha (140 mg/mL). The award, valued at $16,601.13, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, potentially worth up to $999,999,999 through December 2025. The contract does not have a set-aside designation and is for a firm fixed-price delivery order...
- This federal contract award, valued at $5,420.88, was issued by the Defense Logistics Agency's (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Repatha (140 mg/mL). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, the primary vehicle for the company to deliver a range of pharmaceutical...
- This federal contract award, valued at $1,958.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha, a 420 mg/3.5 ml Pushtronx 3.5 ml medication, to support federal healthcare programs. The contract has a completion date of September 26, 2023 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $4,389.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha, a specialty medication used for cardiovascular health, with a delivery order completion date of December 13, 2024. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,660.06 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Repatha (140 mg/mL). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Repatha 140mg/ml 2s medication. The contract, valued at $8,415.84, is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It has an ultimate completion date of November 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml SureClick medication, with a ceiling value of $18,224.41 and a period of performance through April 2025. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,802.64, is for the delivery of Repatha 420 mg/3.5 ml Pushtronx 3.5 ml medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha, a 140 mg/mL SureClick medication, with a ceiling value of $1,041.42 and a completion date of April 14, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,562.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Repatha 140 mg/ml SureClick medication, with an ultimate completion date of April 29, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00. This IDC, designated...